名稱 | β-thalassemia mutation Reference Standard Ⅰ |
型號(hào) | CBPD0001 |
報(bào)價(jià) | ![]() |
特點(diǎn) | β-thalassemia mutation Reference Standard Ⅰ |
產(chǎn)品搜索
相關(guān)文章
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- ADCC/ADCP細(xì)胞篩選模型
- STING激動(dòng)劑和拮抗劑的篩選
- ATCC、DSMZ細(xì)胞庫簡介
- 肺癌靶向治療:腫瘤不進(jìn)展時(shí)間超2年
- IHC第三方質(zhì)控品——病理質(zhì)控基石,精準(zhǔn)診斷起點(diǎn)
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國產(chǎn)PD-1抗體進(jìn)入三期
- 神舟十一號(hào)成功發(fā)射!哪些生物實(shí)驗(yàn)跟著上天了?
- 【盤點(diǎn)】癌癥免疫檢查點(diǎn)療法的現(xiàn)狀與展望
- 【分享】NIST開發(fā)ERBB2- CNV標(biāo)準(zhǔn)品的一些思路
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0001β-thalassemia mutation Reference Standard Ⅰ

- 詳細(xì)內(nèi)容
Introduction | |
Format | Genomic DNA |
Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
Technical Data | |
Mutation 1 | Variation site: Codon 39(C>T) |
DNA Change: c.118C>T | |
Zygosity: Heterozygous | |
Allelic Frequency: 50% | |
Chr position(GRCh37): Chr11:5248004G>A | |
Transcript: NM_000518.5 | |
Mutation 2 | Variation site: IVS-I-110(G>A) |
DNA Change: c.93-21G>A | |
Zygosity: Heterozygous | |
Allelic Frequency: 50% | |
Chr position(GRCh37): Chr11:5248050C>T | |
Transcript: NM_000518.5 | |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | Figure 1. Codon 39(C>T) Heterozygous Figure 2. IVS-I-110(G>A) Heterozygous |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |